Article

Cyanidin-3-O-glucoside alleviates non-alcoholic fatty liver disease through modulation of the gut microbiota

2025-01-01

Abstract excerpt

Abstract Non-alcoholic fatty liver disease (NAFLD) is closely linked to gut microbiota dysbiosis. Cyanidin-3-O-glucoside (C3G) shows therapeutic potential in multiple diseases. It regulates gut microbiota composition and metabolic homeostasis bidirectionally. This study investigates the potential of C3G in alleviating high-fat diet (HFD)-induced NAFLD, with a specific focus on genus_Eubacterium_coprostanoligenes,...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: bbf1090d-45d3-5d7f-be9a-c04e9d25f0f1
DOI: 10.1093/fqsafe/fyaf035

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Cyanidin-3-O-glucoside alleviates non-alcoholic fatty liver disease through modulation of the gut microbiotaDOI 10.1093/fqsafe/fyaf035Read

Multi-omics analysis reveals gut microbiota remodeling and lipid metabolism regulation during the treatment of nonalcoholic fatty liver disease with Yindan Pinggan capsuleSemantic proximity Read

Manipulating the Gut Microbiome to Alleviate Steatotic Liver Disease: Current Progress and ChallengesSemantic proximity Read

The Regulation Effect of Crude Polysaccharides from Cordyceps Militaris on Obesity Control and Gut Microbiota Community via High-Fat Diet-Fed Mice ModelSemantic proximity Read

Impact of Cyanidin-3-Glucoside on Gut Microbiota and Relationship with Metabolism and Inflammation in High Fat-High Sucrose Diet-Induced Insulin Resistant MiceSemantic proximity Read

NAFLD/MASLD and the Gut–Liver Axis: From Pathogenesis to Treatment OptionsSemantic proximity Read

The role of microbiota in nonalcoholic fatty liver disease: mechanism of action and treatment strategySemantic proximity Read

Two unique biological response-modifier glucans beneficially regulating gut microbiota and faecal metabolome in a non-alcoholic steatohepatitis animal model, with potential for applications in human health and diseaseSemantic proximity Read

Therapeutic Mechanisms of Medicine and Food Homology Formula Xiao-Ke-Yin on Glucolipid Metabolic Dysfunction Revealed by Transcriptomics, Metabolomics and Microbiomics in miceSemantic proximity Read

Gut Microbiota Patterns in Patients with Non-Alcoholic Fatty Liver Disease: A Comprehensive Assessment Using Three Analysis MethodsSemantic proximity Read

Influence of Saskatoon Berry and Cyanidin-3-Glucoside on Gut Microbiota and Relationship with Metabolism and Inflammation in High Fat-High Sucrose Diet-Induced Insulin Resistant MiceSemantic proximity Read

Microbial Dysbiosis Linked to Metabolic Dysfunction-Associated Fatty Liver Disease in Asians: Prevotella copri Promotes Lipopolysaccharide Biosynthesis and Network Instability in the Prevotella EnterotypeSemantic proximity Read

Gut microbiome and NAFLD: impact and therapeutic potentialSemantic proximity Read